NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,197 filers reported holding NOVARTIS A G in Q3 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $203,000 | -10.6% | 2,500 | -7.4% | 0.20% | 0.0% |
| Q4 2017 | $227,000 | -2.2% | 2,700 | 0.0% | 0.20% | -5.3% |
| Q3 2017 | $232,000 | +14.9% | 2,700 | +22.7% | 0.21% | +77.8% |
| Q3 2015 | $202,000 | -6.5% | 2,200 | 0.0% | 0.12% | +21.9% |
| Q2 2015 | $216,000 | -0.5% | 2,200 | 0.0% | 0.10% | +9.1% |
| Q1 2015 | $217,000 | +1.9% | 2,200 | -4.3% | 0.09% | +11.4% |
| Q4 2014 | $213,000 | -1.4% | 2,300 | 0.0% | 0.08% | +19.7% |
| Q3 2014 | $216,000 | +3.8% | 2,300 | 0.0% | 0.07% | 0.0% |
| Q2 2014 | $208,000 | – | 2,300 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |